SB 197 – Connecticut
Status: EnactedYear Introduced: 2018
Link: https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&which_year=2018&bill_num=197
BIOLOGICAL PRODUCTS: Concerns biological products, adds biological products to existing law regarding substitution of generic drugs. Requires that within 48-hours of dispensing that the pharmacist shall inform the prescribing practitioner by facsimile, telephone or electronic transmission of the biosimilar substitution.
Key Issues:
PHARMACEUTICALS
Biosimilar or Generic Competition
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found
Leave A Comment